CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,000 | +50.0% | 6,452 | +99.0% | 0.00% | – |
Q2 2023 | $4,000 | -85.2% | 3,242 | -85.1% | 0.00% | – |
Q1 2023 | $27,000 | – | 21,759 | +144960.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 15 | -99.2% | 0.00% | – |
Q2 2021 | $4,000 | -60.0% | 1,980 | -48.5% | 0.00% | – |
Q1 2021 | $10,000 | +66.7% | 3,846 | +32.3% | 0.00% | – |
Q4 2020 | $6,000 | – | 2,908 | +96833.3% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 614 | +29.5% | 0.00% | – |
Q3 2019 | $1,000 | – | 474 | +1002.3% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 43 | -91.5% | 0.00% | – |
Q1 2017 | $4,000 | -50.0% | 504 | -33.5% | 0.00% | – |
Q4 2016 | $8,000 | +100.0% | 758 | +157.8% | 0.00% | – |
Q3 2015 | $4,000 | -20.0% | 294 | -10.6% | 0.00% | – |
Q2 2015 | $5,000 | – | 329 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |